{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:08:16Z","timestamp":1774472896715,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Motivation: Panels of cell lines such as the NCI-60 have long been used to test drug candidates for their ability to inhibit proliferation. Predictive models of in vitro drug sensitivity have previously been constructed using gene expression signatures generated from gene expression microarrays. These statistical models allow the prediction of drug response for cell lines not in the original NCI-60. We improve on existing techniques by developing a novel multistep algorithm that builds regression models of drug response using Random Forest, an ensemble approach based on classification and regression trees (CART).<\/jats:p>\n               <jats:p>Results: This method proved successful in predicting drug response for both a panel of 19 Breast Cancer and 7 Glioma cell lines, outperformed other methods based on differential gene expression, and has general utility for any application that seeks to relate gene expression data to a continuous output variable.<\/jats:p>\n               <jats:p>Implementation: Software was written in the R language and will be available together with associated gene expression and drug response data as the package ivDrug at http:\/\/r-forge.r-project.org.<\/jats:p>\n               <jats:p>Contact: \u00a0riddickgp@mail.nih.gov<\/jats:p>\n               <jats:p>Supplementary Information: \u00a0Supplementary data are available at Bioinformatics online.<\/jats:p>","DOI":"10.1093\/bioinformatics\/btq628","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T04:48:21Z","timestamp":1291697301000},"page":"220-224","source":"Crossref","is-referenced-by-count":157,"title":["Predicting <i>in vitro<\/i> drug sensitivity using Random Forests"],"prefix":"10.1093","volume":"27","author":[{"given":"Gregory","family":"Riddick","sequence":"first","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Song","sequence":"additional","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susie","family":"Ahn","sequence":"additional","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Walling","sequence":"additional","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Borges-Rivera","sequence":"additional","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard A.","family":"Fine","sequence":"additional","affiliation":[{"name":"1 Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, MD and 2Carnegie-Mellon University, Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,12,5]]},"reference":[{"key":"2023012512170662300_B1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"2023012512170662300_B2","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1158\/1535-7163.MCT-06-0787","article-title":"Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data","volume":"6","author":"Covell","year":"2007","journal-title":"Mol. Cancer Therap."},{"key":"2023012512170662300_B3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2105-7-3","article-title":"Gene selection and classification of microarray data using random forest","volume":"7","author":"Diaz-Uriarte","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"2023012512170662300_B4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nbt1397","article-title":"A modular approach for integrative analysis of large-scale gene-expression and drug-response data","volume":"26","author":"Kutalik","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"2023012512170662300_B5","first-page":"18","article-title":"Classification and regression by randomforest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"key":"2023012512170662300_B6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1541-7786.MCR-07-0280","article-title":"Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas","volume":"6","author":"Li","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"2023012512170662300_B7","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1073\/pnas.0610292104","article-title":"A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery","author":"Lee","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023012512170662300_B8","doi-asserted-by":"crossref","first-page":"e6772","DOI":"10.1371\/journal.pone.0006772","article-title":"Utilization of genomic signatures to identify phenotype-specific drugs","volume":"4","author":"Mori","year":"2009","journal-title":"PLoS ONE"},{"key":"2023012512170662300_B9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl Cancer Inst."},{"key":"2023012512170662300_B10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm1491","article-title":"Genomic signatures to guide the use of chemotherapeutics","volume":"12","author":"Potti","year":"2006","journal-title":"Nat. Med."},{"key":"2023012512170662300_B11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"2023012512170662300_B12","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1073\/pnas.191368598","article-title":"Chemosensitivity prediction by transcriptional profiling","volume":"98","author":"Staunton","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023012512170662300_B13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nature Protoc."},{"key":"2023012512170662300_B14","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1158\/1535-7163.MCT-06-0640","article-title":"Spotlight on molecular profiling: \u2018Integromic\u2019 analysis of the NCI-60 cancer cell lines","volume":"5","author":"Weinstein","year":"2006","journal-title":"Mol. Cancer Therap."}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/27\/2\/220\/48866858\/bioinformatics_27_2_220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/27\/2\/220\/48866858\/bioinformatics_27_2_220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T14:49:20Z","timestamp":1674658160000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/27\/2\/220\/284743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,5]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btq628","relation":{},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,1,15]]},"published":{"date-parts":[[2010,12,5]]}}}